Bictegravir 50mg Emtricitabine 200mg and Tenofovir Alfenamide 25mg Tablets

Description

Bictegravir/emtricitabine/tenofovir alafenamide (brand name Biktarvy, TAFFIC) is a fixed dose combination drug for the treatment of HIV-1 infection. It contains 50 mg bictegravir, 200 mg emtricitabine, and 25 mg tenofovir alafenamide.Biktarvy is an example of a combination drug that can be taken as a complete regimen for treatment of the human immunodeficiency virus. Combination therapy for HIV, often called highly active antiretroviral therapy (HAART), is composed of two or more types of antiretroviral drugs. Combination therapy decreases the likelihood that drug resistance will occur, because it is unlikely that the HIV-1 strains will be able to mutate enough to become resistant to all drugs being used in the combination.